Lantheus Holdings Plans to Sell RELISTOR Royalties to HealthCare Royalty, Gets $98M As Initial Payment
Portfolio Pulse from Benzinga Newsdesk
Lantheus Holdings has planned to sell RELISTOR royalties to HealthCare Royalty for an initial payment of $98 million. Lantheus also has the right to receive an additional $5 million if worldwide net sales of RELISTOR in 2025 exceed a specified threshold.
August 04, 2023 | 1:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The sale of RELISTOR royalties to HealthCare Royalty for $98 million provides Lantheus Holdings with a significant cash influx. The potential for an additional $5 million based on 2025 sales could further boost revenues.
The sale of RELISTOR royalties provides Lantheus Holdings with immediate cash, improving its liquidity position. The potential for an additional $5 million based on 2025 sales could provide a future revenue boost. This news is likely to be viewed positively by investors, potentially leading to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100